A SIMPLE HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF FLUOROURACIL TO MONITOR PATIENTS ON REGIONAL INFUSION FOR HEPATIC METASTASES

被引:6
作者
KOKS, CHW [1 ]
VANDERKAM, HJ [1 ]
BROUWERS, JRBJ [1 ]
机构
[1] GEN HOSP DE TJONGERSCHANS,DEPT CLIN PHARM & PHARMACOKINET,POB 10500,8440 MA HEERENVEEN,NETHERLANDS
关键词
Administration; continuous intraportal; Chromatography; high pressure liquid; Fluorouracil;
D O I
10.1007/BF01970157
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A rapid and sensitive high pressure liquid chromatographic method has been developed for the routine monitoring in serum of the antineoplastic agent fluorouracil, during continuous intraportal administration. Serum spiked with internal standard, bromouracil, was gently shaken for 10 min with ethylacetate at an acidic pH. The evaporated extract was dissolved in the mobile phase containing potassium phosphate buffer. Assays were performed at ambient temperature on a Chrompack LiChrosorb RP 18 column (2×100×3.0 mm) equipped with a guard column. The retention time of fluorouracil was 2-6 min. The calibration curve was linear from 25 to 2,000 ng/ml. The coefficient of variation was ≤1.6% for within-run precision and ≤2.9% for day-to-day precision. The mean recovery of fluorouracil was 57%. © 1990 Royal Dutch Association for Advancement of Pharmacy.
引用
收藏
页码:154 / 157
页数:4
相关论文
共 13 条
[1]   REVERSED-PHASE ION-PAIR ANALYSIS OF 5-FLUOROURACIL IN PIG BILE, LIVER HOMOGENATE, PLASMA AND URINE AFTER ADMINISTRATION BY ISOLATED LIVER PERFUSION [J].
BIERMAN, JAC ;
LINGEMAN, H ;
REEUWIJK, HJEM ;
DEBRUIJN, EA ;
TJADEN, UR ;
VANDERGREEF, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (05) :611-617
[2]   PHASE-I AND PHARMACOLOGIC STUDY OF 72-HOUR INFUSED 5-FLUOROURACIL IN MAN [J].
BYFIELD, JE ;
FRANKEL, SS ;
HORNBECK, CL ;
SHARP, TR ;
CALLIPARI, FB ;
FLOYD, RA .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (05) :429-440
[3]  
CALABROJONES PM, 1982, CANCER RES, V42, P4413
[4]  
CHRISTOPHIDIS N, 1979, CLIN CHEM, V25, P83
[5]  
CLARKSON B, 1964, CLIN PHARMACOL THER, V5, P581
[6]   GLC ASSAY FOR 5-FLUOROURACIL IN BIOLOGICAL-FLUIDS [J].
COHEN, JL ;
BRENNAN, PB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (04) :572-575
[7]   QUANTITATIVE-ANALYSIS OF 5-FLUOROURACIL IN HUMAN-SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
DEGREGORIO, MW ;
HOLLERAN, WM ;
BENZ, CC ;
CADMAN, EC .
ANALYTICAL LETTERS PART B-CLINICAL AND BIOCHEMICAL ANALYSIS, 1985, 18 (01) :51-55
[8]  
DRIESSEN O, 1978, J PHARM SCI, V67, P1494, DOI 10.1002/jps.2600671055
[9]   IMPROVED LIQUID-CHROMATOGRAPHIC ASSAY FOR SERUM FLUOROURACIL CONCENTRATIONS IN THE PRESENCE OF FTORAFUR [J].
HORNBECK, CL ;
FLOYD, RA ;
GRIFFITHS, JC ;
BYFIELD, JE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (10) :1163-1166
[10]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF 5-FLUOROURACIL AFTER DERIVATIZATION WITH 4-BROMOMETHYL-7-METHOXYCOUMARIN - CHARACTERIZATION OF THE DERIVATIVE AND THE USE OF COLUMN SWITCHING FOR THE IMPROVEMENT OF RESOLUTION AND THE ENHANCEMENT OF SENSITIVITY [J].
KINDBERG, CG ;
SLAVIK, M ;
RILEY, CM ;
STOBAUGH, JF .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (04) :459-469